Aurobindo Pharma Limited (BOM:524804)
1,497.85
+54.80 (3.80%)
At close: Jun 19, 2026
Aurobindo Pharma Employees
Aurobindo Pharma had 27,707 employees as of March 31, 2025. The number of employees increased by 1,692 or 6.50% compared to the previous year.
Employees
27,707
Change (1Y)
1,692
Growth (1Y)
6.50%
Revenue / Employee
12.15M INR
Profits / Employee
1.26M INR
Market Cap
858.41B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,707 | 1,692 | 6.50% |
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Lupin | 24,006 |
| Torrent Pharmaceuticals | 18,258 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
Aurobindo Pharma News
- 14 hours ago - Aurobindo gets US FTC nod to acquire Lannett Co for $250 million - The Times of India
- 21 hours ago - HSBC maintains Buy on Aurobindo Pharma, sees progress toward $2 billion US sales goal - Business Upturn
- 21 hours ago - Aurobindo Pharma USA receives FTC approval for $250 million acquisition of Lannett - Business Upturn
- 3 days ago - Aurobindo Pharma's subsidiary faces five observations following US FDA inspection - Business Upturn
- 3 days ago - Pharma sector stocks today, June 19: IPCA Labs up 2.54%, Aurobindo Pharma gains 0.93%, Orchid Pharma falls 1.97% - Business Upturn
- 3 days ago - Aurobindo Pharma receives US FTC approval for Lannett acquisition - Business Upturn
- 4 days ago - FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett - Reuters
- 5 days ago - Pharma sector stocks today, June 17: Aurobindo Pharma gains 2.26%, Panacea Biotech falls 1.80%, Cipla down 0.32% - Business Upturn